ACC 2010: Transcatheter Mitral Valve Repair Data Among Expected Highlights
This article was originally published in The Gray Sheet
Executive Summary
A substantial 2009 acquisition by Abbott could be validated and the prospects for Boston Scientific's future drug-eluting stent portfolio weighed from data set to be presented later this month at the American College of Cardiology annual conference